Prospective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria.


Journal

Journal of gastroenterology
ISSN: 1435-5922
Titre abrégé: J Gastroenterol
Pays: Japan
ID NLM: 9430794

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 13 05 2019
accepted: 24 06 2019
pubmed: 5 7 2019
medline: 22 7 2020
entrez: 5 7 2019
Statut: ppublish

Résumé

Chronic pancreatitis (CP) is a fibro-inflammatory disease of the pancreas. Early diagnosis and intervention, before CP becomes established and irreversible, are essential to improve the long-term outcomes. The world's first diagnostic criteria for early CP were proposed in Japan in 2009, but their clinical utility remains elusive. This study aimed to clarify whether patients with early CP progress to definite CP. This is a multicenter, prospective study. Patients diagnosed as having early CP according to the Japanese diagnostic criteria were prospectively followed for 2 years. Clinical profiles including symptoms, drinking and smoking status, laboratory data, imaging findings and treatments were analyzed. Among the 83 patients who completed the 2-year follow-up period, four (4.8%) patients progressed to definite CP. The diagnosis of 48 (57.8%) patients was unchanged, and that of 31 (37.3%) patients was downgraded. All the four progressive patients were male, alcohol-related, smokers (3 current and 1 ever), and continued drinking. Comparison of the clinical profiles between the progression group (n = 4) and non-progression group (n = 79) revealed that etiology (alcohol-related), smoking status and presence of acute pancreatitis episodes were associated with the progression to definite CP. The Japanese diagnostic criteria could identify some patients before the progression to definite CP, while the majority of the patients did not progress. UMIN000015992.

Sections du résumé

BACKGROUND BACKGROUND
Chronic pancreatitis (CP) is a fibro-inflammatory disease of the pancreas. Early diagnosis and intervention, before CP becomes established and irreversible, are essential to improve the long-term outcomes. The world's first diagnostic criteria for early CP were proposed in Japan in 2009, but their clinical utility remains elusive. This study aimed to clarify whether patients with early CP progress to definite CP.
METHODS METHODS
This is a multicenter, prospective study. Patients diagnosed as having early CP according to the Japanese diagnostic criteria were prospectively followed for 2 years. Clinical profiles including symptoms, drinking and smoking status, laboratory data, imaging findings and treatments were analyzed.
RESULTS RESULTS
Among the 83 patients who completed the 2-year follow-up period, four (4.8%) patients progressed to definite CP. The diagnosis of 48 (57.8%) patients was unchanged, and that of 31 (37.3%) patients was downgraded. All the four progressive patients were male, alcohol-related, smokers (3 current and 1 ever), and continued drinking. Comparison of the clinical profiles between the progression group (n = 4) and non-progression group (n = 79) revealed that etiology (alcohol-related), smoking status and presence of acute pancreatitis episodes were associated with the progression to definite CP.
CONCLUSIONS CONCLUSIONS
The Japanese diagnostic criteria could identify some patients before the progression to definite CP, while the majority of the patients did not progress.
TRIAL REGISTRATION NUMBER BACKGROUND
UMIN000015992.

Identifiants

pubmed: 31270692
doi: 10.1007/s00535-019-01602-9
pii: 10.1007/s00535-019-01602-9
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

928-935

Subventions

Organisme : Japan Pancreas Society
ID : 1

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Gut. 1999 Sep;45(3):317-22
pubmed: 10446089
Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S15-7
pubmed: 19896091
Am J Gastroenterol. 2017 Sep;112(9):1366-1372
pubmed: 28762376
Pancreatology. 2019 Jun;19(4):500-506
pubmed: 30910452
Am J Gastroenterol. 2012 Jul;107(7):1096-103
pubmed: 22613906
Gastroenterology. 2015 Nov;149(6):1490-1500.e1
pubmed: 26299411
J Gastroenterol. 2017 Aug;52(8):992-1000
pubmed: 28130705
Pancreatology. 2014 Nov-Dec;14(6):490-6
pubmed: 25224249
Pancreatology. 2018 May 21;:
pubmed: 29793839
Gastroenterology. 2001 Feb;120(3):682-707
pubmed: 11179244
Pancreatology. 2016 Mar-Apr;16(2):218-24
pubmed: 26924663
Lancet. 2016 May 7;387(10031):1957-66
pubmed: 26948434
Nat Rev Dis Primers. 2017 Sep 07;3:17060
pubmed: 28880010
Pancreas. 2007 Nov;35(4):320-6
pubmed: 18090237
J Gastroenterol. 2010 Jun;45(6):584-91
pubmed: 20422433
Arch Intern Med. 2009 Jun 8;169(11):1035-45
pubmed: 19506173
Pancreatology. 2018 Oct;18(7):774-784
pubmed: 30119992
Pancreas. 2013 May;42(4):578-83
pubmed: 23508016

Auteurs

Atsushi Masamune (A)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. amasamune@med.tohoku.ac.jp.

Tatsuhide Nabeshima (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Kazuhiro Kikuta (K)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Shin Hamada (S)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Eriko Nakano (E)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Kiyoshi Kume (K)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Atsushi Kanno (A)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Ai Sato (A)

Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Aizuwakamatsu, Japan.
Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Yuichi Tachibana (Y)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Osamu Inatomi (O)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Satoshi Yamamoto (S)

Department of Gastroenterology, Bantane Hospital, Fujita Health University, Nagoya, Japan.

Tsukasa Ikeura (T)

Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan.

Seiji Futagami (S)

Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School, Tokyo, Japan.

Masashi Taguchi (M)

Third Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Keiji Hanada (K)

Department of Gastroenterology, JA Onomichi General Hospital, Onomichi, Japan.

Kyoko Shimizu (K)

Department of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

Masanobu Kageoka (M)

Department of Gastroenterology, Fujieda Municipal Hospital, Fujieda, Japan.

Tomotaka Saito (T)

Department of Gastroenterology, University of Tokyo, Tokyo, Japan.

Takaaki Eguchi (T)

Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.

Kensuke Kubota (K)

Department of Endoscopy, Yokohama City University Hospital, Yokohama, Japan.

Mamoru Takenaka (M)

Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.

Atsushi Mima (A)

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Atsushi Irisawa (A)

Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Aizuwakamatsu, Japan.
Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Tetsuhide Ito (T)

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Akira Andoh (A)

Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Kazuo Inui (K)

Department of Gastroenterology, Bantane Hospital, Fujita Health University, Nagoya, Japan.

Yoshifumi Takeyama (Y)

Department of Surgery, Kindai University Faculty of Medicine, Osaka, Japan.

Hiroki Yamaue (H)

Second Department of Surgery, Wakayama Medical University, Wakayama, Japan.

Kazuichi Okazaki (K)

Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan.

Tooru Shimosegawa (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH